BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26341194)

  • 1. Establishing On-Site Reference Values for (123)I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative Conditions.
    Nicastro N; Garibotto V; Poncet A; Badoud S; Burkhard PR
    Mol Imaging Biol; 2016 Apr; 18(2):302-12. PubMed ID: 26341194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-site
    Fahmi R; Platsch G; Sadr AB; Gouttard S; Thobois S; Zuehlsdorff S; Scheiber C
    Eur J Hybrid Imaging; 2020 Mar; 4(1):5. PubMed ID: 34191214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
    Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
    Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
    Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
    Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
    Nicastro N; Burkhard PR; Garibotto V
    J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
    Jauković L; Ilić TV; Dopudja M; Ajdinović B
    Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semi-quantitative dopamine transporter standardized uptake value in comparison with conventional specific binding ratio in [123I] FP-CIT single-photon emission computed tomography (DaTscan).
    Wakabayashi Y; Takahashi R; Kanda T; Zeng F; Nogami M; Ishii K; Murakami T
    Neurol Sci; 2018 Aug; 39(8):1401-1407. PubMed ID: 29748936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
    Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver variability, and visual and quantitative parameters of (123)I-FP-CIT SPECT (DaTSCAN) studies.
    Papathanasiou N; Rondogianni P; Chroni P; Themistocleous M; Boviatsis E; Pedeli X; Sakas D; Datseris I
    Ann Nucl Med; 2012 Apr; 26(3):234-40. PubMed ID: 22237674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiquantitative analysis using standardized uptake value in
    Toriihara A; Daisaki H; Yamaguchi A; Kobayashi M; Furukawa S; Yoshida K; Isogai J; Tateishi U
    Clin Imaging; 2018; 52():57-61. PubMed ID: 29909364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
    Marshall VL; Reininger CB; Marquardt M; Patterson J; Hadley DM; Oertel WH; Benamer HT; Kemp P; Burn D; Tolosa E; Kulisevsky J; Cunha L; Costa D; Booij J; Tatsch K; Chaudhuri KR; Ulm G; Pogarell O; Höffken H; Gerstner A; Grosset DG
    Mov Disord; 2009 Mar; 24(4):500-8. PubMed ID: 19117369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
    Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single photon emission computed tomography striatal asymmetry index may predict dopaminergic responsiveness in Parkinson disease.
    Contrafatto D; Mostile G; Nicoletti A; Raciti L; Luca A; Dibilio V; Lanzafame S; Distefano A; Drago F; Zappia M
    Clin Neuropharmacol; 2011; 34(2):71-3. PubMed ID: 21406999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT.
    Davidsson A; Georgiopoulos C; Dizdar N; Granerus G; Zachrisson H
    Ann Nucl Med; 2014 Nov; 28(9):851-9. PubMed ID: 24997753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems.
    Meyer PT; Sattler B; Lincke T; Seese A; Sabri O
    J Nucl Med; 2003 May; 44(5):839-45. PubMed ID: 12732687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does reduced [(123)I]-FP-CIT binding in Huntington's disease suggest pre-synaptic dopaminergic involvement?
    Gamez J; Lorenzo-Bosquet C; Cuberas-Borrós G; Carmona F; Hernández-Vara J; Castilló J; Castell-Conesa J
    Clin Neurol Neurosurg; 2010 Dec; 112(10):870-5. PubMed ID: 20724066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy.
    Nicastro N; Garibotto V; Burkhard PR
    Clin Nucl Med; 2018 Feb; 43(2):e33-e36. PubMed ID: 29215405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.